3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
9
Fatigue
8
Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Hodgkin Disease
5
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large B-Cell, Diffuse
4
Lung Neoplasms
4
Leukemia, Myeloid, Acute
4
Congenital Abnormalities
4
Colorectal Neoplasms
4
Sleep Wake Disorders
3
Sezary Syndrome
3
Sexual Dysfunction, Physiological
3
Sarcoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Follicular
3
Lymphoma
3
Leukemia, Prolymphocytic
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Leukemia, Mast-Cell
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Large Granular Lymphocytic
3
Leukemia, Hairy Cell
3
Interventions
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Arteriovenous Malformations
×
Therapeutics
×
Clear all
NCT04272216
2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
99 enrolled
15 charts